Implementation of clinical guidelines;Implementación de guías clínicas

Revista Espanola de Cardiologia

Volumn 59, Issue SUPPL.3, 2006, Pages 29-35

  Gómez Doblas, Juan José ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Clinical guidelines adherence; Clinical practice guidelines; Quality indicators

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; HEALTH PROGRAM; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT;

EID: 34547628508     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13096255     Document Type: Conference Paper

References (41)

1. Field MJ, Lohr MJ, editores. Clinical Practice Guidelines: Directions for a new program. Washington: National Academy Press; 1990. p. 36-42.
2. Institute of Medicine. To err is human: building a safer health system. Washington: National Academy Press; 2000.
3. Lenfant C. Clinical research to clinical practice. Lost in translation? N Engl J Med. 2003;349:868-74.
4. Hart D. Some reflections on how not to get bitten by a clinical guideline. Heart. 2002;87:501-2.
5. Audlet AM, Greenfield S, Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med. 1990;30:709-14.
6. Grinsahw JM, Rusell IT. Effect of clinical guidelines on medical practice: a systematic review of rigourous evaluation. Lancet. 1993;342:1317-22.
7. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-21.
8. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2004;110:588-636.
9. Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005;26:2706-13.
10. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;335:103-6.
11. Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 1998;31:509-13.
12. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281:1900-5.
13. Califf R. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol. 2002;40:1895-901.
14. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002;23:1177-89.
15. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe Part 2: treatment. European Heart J. 2003:24:464-74.
16. Stafford RS, Radley DC. The Underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41:56-61.
17. Schiele F, Meneveau N, Seronde MF, Caulfield F, Fouche R, Lassabe G, et al. Compliance with guidelines and 1 year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J. 2005;26:873-80.
18. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745-9.
19. Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Foody JM, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;46:1479-87.
20. Anderson HV, Shaw RE, Brindis RG, Klein LW, McKay CR, Kutcher MA, et al. Relationship between procedure indications and outcomes of percutaneous coronary interventions by ACC/AHA Task Force Guidelines. Circulation. 2005;112:2786-91.
21. Masoudi FA, Rathore M, Wang Y, Havranek EP, Curtis JP, Foody JA, et al. National patterns of use and effectiveness of ACEI in older patients with heart failure. Circulation. 2004;110:724-31.
22. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, Van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure. The MAHLER survey. Eur Heart J. 2005;26:1653-9.
23. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459-67.
24. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? JAMA. 1999;282:1458-65.
25. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
26. Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: The relationship between clinic experience and quality of health care. Ann Intern Med. 2005;142:260-73.
27. Aros F. Los registros de infarto de miocardio: una oportunidad de mejora. El estudio PREVESE II. Rev Esp Cardiol. 2002;55:791-2.
28. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G, en nombre del Grupo de Investigadores del Estudio PREVESE II. Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II. Rev Esp Cardiol. 2002;55:801-9.
29. Bosch X, López de Sa E, López Sendón J, Aboal J, Miranda-Guardiola F, Bethencourt A, et al. Perfil clínico, pronóstico y variabilidad en el tratamiento del síndrome coronario agudo sin elevación del segmento ST. Datos del registro PEPA. Rev Esp Cardiol. 2003;56:346-53.
30. Muñiz J, Gómez Doblas JJ, Santiago MI, De Teresa E, Cruz JM, A Castro; en nombre del grupo de investigadores del estudio CAM. Efecto de un programa sencillo de educación de los profesionales en el cumplimiento de medidas de prevención secundaria al alta hospitalaria tras un síndrome coronario agudo. Proyecto CAM. Rev Esp Cardiol. 2004;57:1017-28.
31. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand ST. ACC and AHA methodology for the selection and creation of performance measures for quantifyng the quality of cardiovascular care. Circulation. 2005;111:1703-12.
32. Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW. Improving quality improvement using achievable benchmarks for physician feedback. A randomized controlled trial. JAMA. 2001;285:2871-9.
33. Beck CA, Richard H, Tu JV, Pilote L. Administritative data feedback for effective cardiac treatment: AFFECT, a cluster randomized trial. JAMA. 2005;294:309-17.
34. Parsons HM. What happened at Hawthorne? Science. 1974;183:922-32.
35. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. ACC key elements and data definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38:2114-30.
36. Cabrera F, Gómez Doblas JJ, Ruiz M, Jiménez-Navarro MF, Rodríguez I, Espinosa JS, et al. Garantía y mejora de calidad de la atención al paciente con infarto agudo de miocardio. Implantación de un programa de calidad. Rev Esp Cardiol. 2001;54:43-8.
37. Romero A, Alonso C, Marín I, Grimshaw J, Villar E, Rincón M, et al. Efectividad de la implantación de una guía clínica sobre la angina inestable mediante una estrategia multifactorial. Ensayo clínico aleatorizado en grupos. Rev Esp Cardiol. 2005;58:640-8.
38. De Velasco JA, Cosín J, Oya M, De Teresa E, en nombre del grupo de investigadores del estudio PRESENTE. Programa de intervención para mejorar la prevención secundaria del infarto de miocardio. Resultados del estudio PRESENTE. Rev Esp Cardiol. 2004;57:146-54.
39. Eagle KA, Montoye CK, Riba AL, DeFranco AC, Parrish R, Skorcz S, et al. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol. 2005;46:1242-8.
40. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-22.
41. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get with the guidelines for cardiovascular secondary prevention. Arch Intern Med. 2004;164;203-9.